INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Open-market sale
SELL$16K
1,996 sh
Jul 2, 2026Jul 2, 2026
Page 195 of 481
← PrevNext →
traded Jul 2, 2026
+0d
SEC Form 4

Evidence

19
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$4.80M
56.5K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

19
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.60M
18.7K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

19
RM
Rogers Daniel MarkDirector, Chief Executive Officer
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
13.8K sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

17
LJ
Lopez Gustavo JavierDirector
LNDBrasilAgro - Brazilian Agricultural Real Estate Co
Open-market sale
SELL$6,980
2,000 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

16
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$723K
90.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

15
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,200 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

13
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
2,438 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

13
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
741 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
3,900 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
3,500 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$208K
12.8K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,305 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

47
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$99K
22.3K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

39
BF
Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$72K
21.2K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

39
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$116K
25.9K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

39
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Open-market sale
SELL$101K
2,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

36
ZE
Zafrani EdenCHRO
NYAXNayax Ltd.
Open-market sale
SELL$32K
500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

36
TE
Tamayo Louis EdwardChief Financial Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,641 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

32
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,666 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BM
Berho Corona Lorenzo ManuelDirector
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$12K
3,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

22
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
BF
Barone FrancescaChief Scientific Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
23.4K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$311K
900 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$552K
26.6K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

19
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
1,416 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
TS
Tyagarajan SeshuChief Technology Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
7,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

14
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
7,500 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$246K
15.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$6,020
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
2,500 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
15.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

50
RZ
Richmond Raphaell Z.VP, GC & Chief Compliance Off
LZBLA-Z-BOY INC
Open-market sale
SELL$545K
13.7K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

44
HA
Hunt Jolie A.Director
NYSEKRCKILROY REALTY CORP
Open-market sale
SELL$597K
15.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

41
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.70M
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

40
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 10, 2026Jun 30, 2026
traded Jun 10, 2026
+20dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K